Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K on November 2, 2021, to announce its financial results for the third quarter ended September 30, 2021. The key information provided in this filing is a press release detailing the company's performance during the quarter. This report serves as a notification of the results, and the details are within the furnished press release (Exhibit 99.1), which is not deemed 'filed' under Section 18 of the Exchange Act but is furnished for informational purposes. Investors should refer to the press release issued on November 2, 2021, for specific financial metrics, including revenue, earnings per share, and any forward-looking guidance. This 8-K filing itself primarily confirms the release of this information and its availability to the public.
Key Highlights
- 1IDEXX Laboratories announced its third-quarter 2021 financial results on November 2, 2021.
- 2The filing is an 8-K Current Report, primarily furnishing a press release with the financial results.
- 3Exhibit 99.1 contains the full press release detailing the third-quarter performance.
- 4Information furnished under Item 2.02 is not considered 'filed' for Section 18 liability purposes.
- 5Investors need to consult the referenced press release for detailed financial performance and operational updates.
- 6The filing is dated November 2, 2021, with the event date of the results announcement also being November 1, 2021.